Dave Bennett, 57, who received the first heart transplant from a genetically modified pig, is breathing on his own, and speaking with a quiet voice.
Author: Karen Weintraub, USA TODAY
The pandemic is changing. Will omicron bring a ‘new normal’ for COVID-19?
Experts say it’s too soon to know for sure what the coronavirus will do next, but one thing is clear: the world is going to have to live with COVID-19.
First pig-to-human heart transplant offers hope for thousands in need of organs
The breakthrough by doctors at the University of Maryland offers hope for those who languish on organ transplant waitlists.
Technology used in mRNA COVID vaccines offers hope for treatment of millions with heart disease, study suggests
For now the success by University of Pennsylvania researchers has only been achieved in mice, but it offers hope for millions of people with fibrosis.
Trailblazing gene therapy offers promise of curing rare diseases before they take hold
in the coming years, scientists hope to end a number of illnesses that have caused misery for generations.
New COVID treatments are coming. Will they be here in time to combat the omicron onslaught?
New antiviral COVID-19 treatments are coming but getting enough supply to fight the omicron variant surge is a concern.
Could treatments for rare diseases be found in neighborhood pharmacies? New uses for old drugs offer promise
For patients with extremely rare diseases, repurposing existing drugs may be their only hope.
A year after first COVID-19 vaccine, here’s what’s next for researchers – and what worries them
On the one year anniversary of the first COVID vaccines being given, what do researchers have their sights set on? Perhaps, a future without shots.
‘Our best defense’: Pfizer says third dose of its COVID vaccine protects against omicron
A third dose of the Pfizer-BioNTech vaccine appears to be as effective against omicron as two doses were against the original variant.
What’s in a name? For families desperate for a diagnosis, knowing the cause of illness matters
Medicine has made strides understanding rare genetic diseases but many patients, often children, face a diagnostic odyssey to find out what is wrong.